Combining Bevacizumab with Temozolomide Increases the Antitumor Efficacy of Temozolomide in a Human Glioblastoma Orthotopic Xenograft Model

Ítems similars

• The sodium pump α1 sub-unit: a disease progression–related target for metastatic melanoma treatment
  per: Mathieu, Véronique, et al.
  Publicat: (2009)
• Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis
  per: Celina Bihan, et al.
  Publicat: (2012-09-01)
• Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis
  per: Bihan, Celina, et al.
  Publicat: (2012)
• Amaryllidaceae Isocarbostyril Alkaloids and Their Derivatives as Promising Antitumor Agents
  per: Ingrassia, Laurent, et al.
  Publicat: (2008)
• Evaluation of MGMT Promoter Methylation Status and Correlation with Temozolomide Response in Orthotopic Glioblastoma Xenograft Model
  per: Kitange, Gaspar J., et al.
  Publicat: (2008)